8
Oct
2024

GM PHARMA

Exhibitor at CPHI Milan 2024 stand 16B60, Finished Dosage Formulations
About Us

GM PHARMA is an international pharmaceutical company with medicines & FS manufactured in GMP-certified manufacturing plants in Western EU countries and in its ow GMP-certified manufacturing plant in Georgia. GM Pharma's solid dosage forms manufacturing site in Tbilisi, Georgia, is the largest pharmaceutical plant in the Caucasus region. Company employs more than 600 professionals including those employed in its export countries. With >140 brands and >230 dosage forms in its portfolio, GM Pharma holds one of the broadest product portfolio in the region.

  • GE
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16B60, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Turbomicron G

    Product Turbomicron G

    Diosmin / Hesperidin Purified Micronized Fractions
  • Azimac

    Product Azimac

    Azithromycin
  • Lacto G Forte

    Product Lacto G Forte

    3 Bifidumbacterium, Lactobacillus, FOS
  • Trimeik

    Product Trimeik

    Perindopril / Indapamide / Amlodipine
  • Zetor Plus

    Product Zetor Plus

    Rosuvastatin / Ezetimibe 5mg/10mg; 10mg/10mg; 20mg/10mg

GM Pharmaceuticals Resources (1)